Details werden geladen...
LVMH Reports 2% Organic Revenue Growth In First Nine Months Of 2026 | 13.10.26 | finanzen.at
(RTTNews) - LVMH (MC.PA, LVMHF.PK, MOH.DE) on Monday reported revenue of €57.15 billion for the first nine months of 2026, down 2% from €58.09 bil...
Ähnliche Seiten
LVMH Reports 2% Organic Revenue Growth In First Nine Months Of 2026 | 13.10.26 | finanzen.ch
https://www.finanzen.ch/nachrichten/aktien/lvmh-reports-2percent-organic-revenue-growth-in-first-nine-months-of-2026-1036618537
PowerBank FY26 Loss Narrows, Expects Revenue Growth In FY27 | 29.09.26 | finanzen.at
https://www.finanzen.at/nachrichten/aktien/powerbank-fy26-loss-narrows-expects-revenue-growth-in-fy27-1036582047
Kaufman & Broad SA: RESULTS FOR THE FIRST NINE MONTHS OF 2026
https://www.finanznachrichten.de/nachrichten-2026-09/69721797-kaufman-broad-sa-results-for-the-first-nine-months-of-2026-015.htmEQS-Adhoc: SGL Carbon SE reports preliminary sales and earnings figures for the first nine months and raises its forecast for 2026 | 06.10.26 | finanzen.at
https://www.finanzen.at/nachrichten/aktien/eqs-adhoc-sgl-carbon-se-reports-preliminary-sales-and-earnings-figures-for-the-first-nine-months-and-raises-its-forecast-for-2026-1036601457Genmab Reports Positive Phase 1/2 Data For Rina-S In Resistant Ovarian Cancer | 04.10.26 | finanzen.at
https://www.finanzen.at/nachrichten/aktien/genmab-reports-positive-phase-1-2-data-for-rina-s-in-resistant-ovarian-cancer-1036595477